⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

June 1, 2023Hepatic OncologyOpen Access

Hepatic Arterial Infusion Chemotherapy with or without Lenvatinib for Unresectable Cholangiocarcinoma: A Single-Center Retrospective Study

Yajing Wang Zhanqi Wei Zheng Zhang Jingyi Xu Yaqin Wang Qian Chen Yuewei Zhang

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

FOLFOX-HAIC plus lenvatinib has the potential to be a treatment option for unresectable cholangiocarcinoma.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2023) studied this question.

synapsesocial.com/papers/69dab34e4a1e15904c835c18 https://doi.org/10.2217/hep-2023-0006

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Current epidemiology of cholangiocarcinoma in Western countriesOriginal Research · 2022 · 206 citations
2Cholangiocarcinoma 2020: the next horizon in mechanisms and managementClinical Guideline · 2020 · 2,411 citations
3Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for cliniciansReview · 2022 · 453 citations
4Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic CholangiocarcinomaEarly-Phase Clinical Trial · 2019 · 232 citations
5Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy aloneRetrospective Study · 2015 · 201 citations
6Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerCohort Study · 2010 · 4,549 citations
7Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic CholangiocarcinomaRetrospective Study · 2022 · 62 citations
8Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort studyCohort Study · 2022 · 14 citations
9Treatment patterns and outcomes in US patients with unresectable HCC treated with embolizationHepatic Oncology · 2026
10Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinomaHepatic Oncology · 2026

More from Hepatic Oncology

More from Tsinghua University

More from Beijing Tsinghua Chang Gung Hospital